This resource is no longer available
NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the introduction of biosimilars and identify opportunities for technology solutions to reduce the administrative burden.
• Lessons learned from biosimilars in oncology treatment
• The significant impact biosimilars will have on treatment considerations for autoimmune diseases
• Steps payers can take to prepare for the changing landscape
NantHealth, a member of the NantWorks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights. NantHealth helps payers and providers work together to ensure patients receive timely, optimal care at the best cost. NantHealth’s product portfolio comprises the latest technology in payer/provider collaboration platforms for real-time decision support (Eviti and NaviNet).